3SBio Inc. , Nasdaq: SSRX
A leading Chinese biotech with drugs for anemia and low blood platelets.
Industry: Health Care
First Day Return: -7.2%
Industry: Health Care
SSRX
A leading Chinese biotech with drugs for anemia and low blood platelets.
| IPO Data | |
|---|---|
| IPO File Date | 01/19/2007 |
| Offer Price | $16.00 |
| Price Range $12.00 - $14.00 | |
| Offer Shares (mm) | 7.7 |
| Deal Size ($mm) | $123 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/06/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $123 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Shenyang, China |
| Founded | 1993 |
| Employees at IPO | n/a |
| Website www.3sbio.com | |
IPO News for 3SBio Inc.
3SBio Inc. (SSRX) Performance
